ESOTERIX GENETIC LABORATORIES LLC

Esoterix Genetic Laboratories LLC specializes in advanced genetic and clinical testing services, operating as a high-complexity clinical laboratory delivering precision diagnostics and analytical support to federal health agencies. Their core capabilities encompass molecular diagnostics, biomarker analysis, and laboratory testing protocols aligned with regulatory standards for public health surveillance and biomedical research. The contractor provides end-to-end testing infrastructure, including sample processing, data interpretation, and quality-controlled reporting, with a focus on assays used in population health initiatives and clinical trial support. Their technical expertise lies in standardized laboratory workflows compliant with CLIA and CAP guidelines, ensuring reproducible, high-acuity results for government-funded health programs. The company maintains a consistent relationship with the Department of Health and Human Services, delivering laboratory testing services under long-term agreements that support national health monitoring, infectious disease tracking, and genetic screening initiatives. Their engagements reflect a pattern of sustained, mission-critical support rather than one-time procurements, indicating deep integration into HHS operational frameworks. Esoterix operates primarily under NAICS 541380 (Testing Laboratories and Services) and 621511 (Medical Laboratories), positioning itself within the federal biomedical diagnostics market as a specialized provider of clinical laboratory services. Their work supports public health infrastructure, epidemiological research, and precision medicine programs requiring accredited, high-throughput testing environments. As a privately held entity based in Westborough, Massachusetts, Esoterix Genetic Laboratories LLC functions as a non-certified small business with no active government certifications. Their geographic presence is centered in New England, with a focused footprint in federal health contracting markets. The company’s market positioning is defined by technical rigor in genetic and clinical testing, serving as a trusted provider for complex, regulated diagnostic work within the federal health ecosystem.